Speak directly to the analyst to clarify any post sales queries you may have.
Veterinary antimicrobial susceptibility testing is evolving rapidly, intersecting advancements in diagnostics, regulatory oversight, and animal health. This report offers in-depth, actionable insights tailored for senior decision-makers navigating this dynamic industry landscape.
Market Snapshot: Veterinary Antimicrobial Susceptibility Testing Market
The veterinary antimicrobial susceptibility testing market grew from USD 113.38 million in 2024 to USD 123.33 million in 2025 and is projected to reach USD 221.88 million by 2032, reflecting a compound annual growth rate of 8.75%. Key drivers include adoption of automated platforms, expanding global animal health needs, and regulatory focus on antibiotic stewardship.
Scope & Segmentation
This comprehensive report provides coverage across all core market dimensions and technologies shaping the veterinary antimicrobial susceptibility testing landscape.
- Test Types: Automated systems (MicroScan, PHOENIX, VITEK, WalkAway); Broth microdilution (automated and manual); Disk diffusion; Etest; Molecular methods including LAMP, next-generation sequencing (NGS), PCR, and QPCR.
- Animal Types: Aquaculture; Companion animals; Equine; Livestock; Poultry.
- End Users: Pharmaceutical and biotechnology firms; Research institutes; Veterinary diagnostic laboratories; Veterinary hospitals and clinics.
- Pathogen Types: Fungi; Gram-negative bacteria; Gram-positive bacteria; Mycobacteria.
- Sample Types: Blood; Milk; Swab; Tissue; Urine.
- Product Types: Instruments (automated, bench-top); Kits and reagents (consumables, reagents); Software and services (data management, technical support, consulting).
- Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru); Europe, Middle East, and Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, UAE, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan).
- Key Companies Profiled: Thermo Fisher Scientific Inc, bioMérieux SA, Becton Dickinson and Company, IDEXX Laboratories Inc, Bruker Corporation, Creative Diagnostics, Merck & Co Inc, Eurofins Scientific SE, SGS SA, Bio-Rad Laboratories.
Key Takeaways for Decision-Makers
- Automation and molecular innovations are accelerating diagnostic speed and precision, influencing laboratory adoption worldwide.
- Stakeholders are restructuring workflows and business models to adapt to evolving regulatory standards and antibiotic stewardship mandates.
- Strategic partnerships among instrument manufacturers, local distributors, and software providers are increasingly important for broadening market reach and service scalability.
- Segment diversity—spanning test type, target animal species, and pathogen variety—demands flexible, integrated solutions to address specific clinical and operational requirements.
- Veterinary diagnostic providers are pursuing multidisciplinary collaborations to leverage emerging data analytics and predictive models in resistance management.
Tariff Impact: Navigating Cost Pressures in 2025
New U.S. tariffs on imported reagents and diagnostics have increased input costs for many veterinary laboratories. This shift is driving reassessment of supplier relationships, greater focus on cost optimization, and an uptick in regional manufacturing partnerships. Laboratories are balancing competitive service pricing with margin preservation, prompting enhanced automation, supply chain resilience, and closer collaboration with distribution networks.
Methodology & Data Sources
Insights in this report derive from a rigorous blend of secondary research and structured primary interviews with laboratory leaders, clinicians, R&D executives, and regulatory experts. Data triangulation processes and scenario analyses underpin data integrity, while veterinary microbiology specialists review findings for accuracy and practical application.
Why This Report Matters
- Enables informed, strategic investments in automated and molecular testing platforms in line with global regulatory trends and regional operational constraints.
- Supports executive decision-makers in optimizing lab workflows, managing supply chain challenges, and aligning technology adoption with current and future resistance threats.
- Provides clear segmentation analysis and action-focused recommendations to guide product development, market entry, and partnership initiatives within the evolving animal health ecosystem.
Conclusion
Veterinary antimicrobial susceptibility testing is shaped by innovation, regulation, and economic shifts. Organizations that align technology, workflows, and strategic partnerships stand to strengthen their market position and advance animal health outcomes.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
List of Figures
Samples
LOADING...
Companies Mentioned
The key companies profiled in this Veterinary Antimicrobial Susceptibility Testing market report include:- Thermo Fisher Scientific Inc.
- bioMérieux SA
- Becton, Dickinson and Company
- IDEXX Laboratories, Inc.
- Bruker Corporation
- Creative Diagnostics
- Merck & Co., Inc.
- Eurofins Scientific SE
- SGS SA
- Bio-Rad Laboratories
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 195 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 123.33 Million |
| Forecasted Market Value ( USD | $ 221.88 Million |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
